Details for New Drug Application (NDA): 013295

NDA 013295 describes CONRAY 43, which is a drug marketed by Liebel-flarsheim and is included in one NDA. It is available from one supplier. Additional details are available on the CONRAY 43 profile page.

The generic ingredient in CONRAY 43 is iothalamate meglumine. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the iothalamate meglumine profile page.

Summary for 013295

Tradename:	CONRAY 43
Applicant:	Liebel-flarsheim
Ingredient:	iothalamate meglumine
Patents:	0

Pharmacology for NDA: 013295

Mechanism of Action

X-Ray Contrast Activity

Medical Subject Heading (MeSH) Categories for 013295

Contrast Media

Suppliers and Packaging for NDA: 013295

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CONRAY	iothalamate meglumine	INJECTABLE;INJECTION	013295	NDA	Liebel-Flarsheim Company LLC	0019-0953	0019-0953-05	25 VIAL, GLASS in 1 BOX (0019-0953-05) / 50 mL in 1 VIAL, GLASS
CONRAY	iothalamate meglumine	INJECTABLE;INJECTION	013295	NDA	Liebel-Flarsheim Company LLC	0019-0953	0019-0953-10	12 BOTTLE, GLASS in 1 BOX (0019-0953-10) / 100 mL in 1 BOTTLE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	60%
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	43%
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	Yes

Complete Access Available with Subscription